Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | New inflation numbers reveal good news for home loan borrowers | ||
Do | Pure Hydrogen signals a name change with rebrand to Pure One | ||
Do | The Fed didn't move - but investors should | ||
Do | Disorder to go: Tackling the deadliest psychological illnesses no one is talking about | ||
Do | Everything you need to know about batteries and then some | ||
Do | High Voltage: Rare earths at the heart of Trump tariff saga this week | ||
Do | Resources Top 5: Infini Resources revs up quest for Canadian uranium | ||
Do | Closing Bell: Resources weigh heavy on ASX, down 0.16pc as tech rally fizzles | ||
Do | YouTube roped into Labor's social media ban for under 16s | ||
Do | ASX Health Quarterly Wrap: Control Bionics makes 15pc sales revenue jump | ||
Do | AFL Round 21 Predictions: Can Jezza nail an in-season ton? | ||
Do | Signal warns it will leave Australia if forced to hand over messages | ||
Do | Lunch Wrap: ASX struggles as copper takes a beating | ||
Do | ASX Resources Quarterly Wrap: These ASX plays are thriving in Canada | ||
Do | Health Check: Today's flood of last-minute quarterly 'homework' scores a solid pass | ||
Do | ASX Health Quarterly Wrap: PainChek grows aged care presence, EMVision starts pivotal trial | ||
Do | Break it Down: St George discovery could supersize Araxá REE-niobium | ||
Do | Top 10 at 11: ASX dives as Fed gives hawkish vibes | ||
Mi | Lithium might be back but the ride will be wild | ||
Mi | Silver prices are soaring and these ASX juniors are along for the ride | ||
Mi | Doubling up: How ASX biotechs are multiplying their impact | ||
Mi | ASX explorers watch closely as Brazil scrambles to defuse US trade tensions | ||
Mi | ASX Health Quarterly Wrap: Neurizon turns up the dial on ALS drug progress | ||
Mi | Closing Bell: ASX climbs back toward record highs as inflation softens | ||
Mi | Resources Top 5: Gold results point to much bigger Little Gem for Ora Banda |